Published: 6 February 2020
Author(s): Luis Castilla-Guerra, Jose Antonio Perez de Leon, María del Carmen Fernandez-Moreno
Section: Letter to the Editor

Internists often treat patients with dyslipidemia or atherosclerotic cardiovascular disease (ASCVD); however, there remain questions regarding what degree of reduction in low density lipoprotein cholesterol (LDL-C) is sufficient, and what supporting evidence there is for this.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.